Literature DB >> 6252284

The isolation and characterization of a clonally related series of murine retrovirus-infected mouse cells.

A Morris, C Clegg, J Jones, B Rodgers, R J Avery.   

Abstract

Starting with cloned NIH 3T3 mouse cells we have isolated a series of related lines infected with the Kirsten murine sarcoma/leukaemia (MSV/MLV) virus complex. These lines exhibit all three possible infected cell phenotopes: (i) transformed MSV/MLV producers; (ii) non-transformed MLV producers; (iii) transformed non-producers. We have also selected non-transformed revertants from one of the non-producer clones. This series of lines allows the study of the expression of the virus genome against a constant background of cellular gene expression. We have further characterized the lines with regard to anchorage dependence of growth, tumorigenicity and the presence of a rescuable sarcoma genome. The non-producer clones are uniform in their transformed properties. The revertants contain rescuable sarcoma virus, biologically indistinguishable from the original transforming virus, implying that the reversion is due to a change in cellular rather than viurs genetic information.

Entities:  

Mesh:

Year:  1980        PMID: 6252284     DOI: 10.1099/0022-1317-49-1-105

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  12 in total

1.  Temperature-sensitive cellular mutant for expression of mRNA from murine retrovirus.

Authors:  H Inoue; S Kizaka; M Yutsudo; A Hakura
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Detection of genes with a potential for suppressing the transformed phenotype associated with activated ras genes.

Authors:  M Noda; H Kitayama; T Matsuzaki; Y Sugimoto; H Okayama; R H Bassin; Y Ikawa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

3.  A recessive cellular mutation in v-fes-transformed mink cells restores contact inhibition and anchorage-dependent growth.

Authors:  J R Haynes; J R Downing
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

4.  Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion.

Authors:  J D Norton; F Cook; P C Roberts; J P Clewley; R J Avery
Journal:  J Virol       Date:  1984-05       Impact factor: 5.103

5.  Biochemical characterization of a deleted Kirsten sarcoma virus genome. Brief report.

Authors:  J P Clewley; J D Norton; R J Avery
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

6.  A cell mutant that exhibits temperature-dependent sensitivity to transformation by various oncogenes.

Authors:  S Kizaka; A Hakura
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

7.  Independent regulation of mouse VL30 retrotransposon expression in response to serum and oncogenic cell transformation.

Authors:  L Eaton; J D Norton
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

8.  The virion RNA species of the Kirsten murine sarcoma-leukemia virus complex released from a clonally related series of mouse cells.

Authors:  J P Clewley; R J Avery
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

9.  Loss of epidermal growth factor receptors and release of transforming growth factors do not correlate with sarcoma virus-transformation in clonally-related NIH/3T3-derived cell lines.

Authors:  K D Brown; D M Blakeley; P Roberts; R J Avery
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

10.  A novel approach to cloning transcriptionally active retrovirus-like genetic elements from mouse cells.

Authors:  A T Carter; J D Norton; R J Avery
Journal:  Nucleic Acids Res       Date:  1983-09-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.